Nov 04, 2019
Aeromics and Simcere Announce Collaboration and License Agreement for AER-271 in Greater China
Sep 09, 2019
Aeromics, Inc. Appoints Nobel Laureate Peter Agre to Its Board of Directors
Jun 13, 2019
Global Ion Channel Modulators Markets, 2015-2019 & 2022: Recent Industry Activity / Industry Overview / Focus on Select Players
Feb 13, 2019
Global Ion Channel Modulators Market Analysis, Trends, and Forecasts 2015-2019 & 2022 - Ion Channel Modulators Find Extensive Use in Neglected Tropical Diseases
Jan 28, 2019
Global Ion Channel Modulators Industry
Dec 13, 2018
Sosei Heptares Starts New Clinical Development Program - First Subject Dosed in Phase I Study of HTL0014242, a Selective mGlu5 Negative Allosteric Modulator in Development to Treat Psychiatric and Neurological Disorders
Jul 19, 2018
SiteOne Therapeutics to Present Research Findings for Selective Small Molecule Nav1.7 Inhibitors at the 2018 World Congress on Pain
Apr 13, 2018
Tolero Pharmaceuticals to Present Preclinical Data Supporting Apoptosis-Inducing Activity of Alvocidib in Acute Myeloid Leukemia
Apr 12, 2018
Ascentage Pharma Announces Five Abstracts To Be Presented at the 2018 American Association for Cancer Research Annual Meeting
Jan 24, 2018
Ion Channel Modulators Markets 2015-2018 & 2022 - Global Strategic Business Report 2018: Their Types, Functional Use and Diversity
Jan 24, 2018
Research Collaboration between the San Francisco VA, UCSF and CalciMedica, Inc. to Present Results on CRAC Channel Inhibitors in a Stroke Model at International Conference
Oct 05, 2017
Heptares Founder Richard Henderson Receives Nobel Prize in Chemistry 2017 for Pioneering Work in Cryo-EM for Visualising Biological Structures
Aug 31, 2017
Heptares Enters a New Research and Drug Discovery Collaboration Under its 'Orbit' Initiative with Juntendo University
Aug 02, 2017
Beta-Secretase (BACE) Inhibitors Pipeline Analysis, 2017 - 15 Product Candidates in Different Stages of Development